APLT APPLIED THERAPEUTICS INC US FDA Inspections 8-K Filing 2024 - FDA extends review period for govorestat Applied Therapeutics Inc. announced that the FDA has extended the review period for the New Drug Application for govorestat by three months.Get access to all SEC 8-K filings of the APPLIED THERAPEUTICS INC